Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMCY-0098 in Recent Onset Type 1 Diabetes
NCT04524949Phase 2Terminated
- Sponsor
- Imcyse
- Start
- Dec 2020
- Primary completion
- Jan 2024
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Peptides
- Countries
- 8
01
Overview
A Phase 2 trial of imcy-0098 in type 1 diabetes mellitus (T1D), sponsored by Imcyse. Started Dec 2020; status: terminated.
02
Drugs
imcy-0098
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04524949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04524949.